Study Finds Short-Term Vaping May Trigger Inflammatory Lung Disease

According to foreign media SlashGear, a study from Ohio State University found that even short-term use of e-cigarettes can trigger inflammation in adults who have never smoked before. This is the first time researchers have discovered that "never smokers" can experience lung changes from short-term e-cigarette use, highlighting the potential health risks of e-cigarettes and similar products.<\/p>

The study involved participants using e-cigarettes for four weeks, with the e-liquid containing no flavoring or nicotine. After four weeks, participants underwent bronchoscopy, revealing cellular changes due to inflammation.
 <\/p>

Since this study excluded nicotine and flavoring, the results suggest that propylene glycol and vegetable glycerin (the two main components in e-liquids) may pave the way for inflammatory lung diseases in e-cigarette users. Inflammation is also a driving factor in cancer development.<\/p>

The senior author of the study, Dr. Peter Shields, stated:<\/p>

The significance of this study lies in the long-term use, increased daily usage, and the addition of flavoring and nicotine, which may promote further inflammation. The public generally believes that e-cigarettes are "safer" than traditional cigarettes. The reality is that the industry is changing so rapidly, regulatory requirements are extremely low, and usage rates are outpacing our scientific understanding.<\/p>

This study, along with an increasing number of studies, analyzes the health impacts of e-cigarettes. Although past studies involved participants using e-cigarettes for longer periods and included flavored e-liquids, this is not the first study to find inflammation from e-cigarette use.